Abstract:Since most dominant human mutations are single nucleotide substitutions<a href="/articles/s41591-019-0500-9#ref-CR1">1</a>,<a href="/articles/s41591-019-0500-9#ref-CR2">2</a>, we explored gene editing strategies to disrupt dominant mutations efficiently and selectively without affecting wild-type alleles. However, single nucleotide discrimination can be difficult to achieve<a href="/articles/s41591-019-0500-9#ref-CR3">3</a> because commonly used endonucleases, such as Streptococcus pyogenes Cas9 (SpCas9), can tolerate up to seven mismatches between guide RNA (gRNA) and target DNA. Furthermore, the protospacer-adjacent motif (PAM) in some Cas9 enzymes can tolerate mismatches with the target DNA<a href="/articles/s41591-019-0500-9#ref-CR3">3</a>,<a href="/articles/s41591-019-0500-9#ref-CR4">4</a>. To circumvent these limitations, we screened 14 Cas9/gRNA combinations for specific and efficient disruption of a nucleotide substitution that causes the dominant progressive hearing loss, DFNA36. As a model for DFNA36, we used Beethoven mice<a href="/articles/s41591-019-0500-9#ref-CR5">5</a>, which harbor a point mutation in Tmc1, a gene required for hearing that encodes a pore-forming subunit of mechanosensory transduction channels in inner-ear hair cells<a href="/articles/s41591-019-0500-9#ref-CR6">6</a>. We identified a PAM variant of Staphylococcus aureus Cas9 (SaCas9-KKH) that selectively and efficiently disrupted the mutant allele, but not the wild-type Tmc1/TMC1 allele, in Beethoven mice and in a DFNA36 human cell line. Adeno-associated virus (AAV)-mediated SaCas9-KKH delivery prevented deafness in Beethoven mice up to one year post injection. Analysis of current ClinVar entries revealed that ~21% of dominant human mutations could be targeted using a similar approach.

In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness

A base editor for the long-term restoration of auditory function in mice with recessive profound deafness

PAM-flexible Adenine Base Editing Rescues Hearing Loss in a Humanized MPZL2 Mouse Model Harboring an East Asian Founder Mutation

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor

Genetic Correction of TRMU Allele Restored the Mitochondrial Dysfunction-Induced Deficiencies in Ipscs-Derived Hair Cells of Hearing-Impaired Patients.

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

Template-independent Genome Editing in the Pcdh15 Mouse, a Model of Human DFNB23 Nonsyndromic Deafness

Gene editing in a Myo6 semi-dominant mouse model rescues auditory function

Template-independent genome editing in the <i>Pcdh15<SUP>av-3j</SUP></i> mouse, a model of human DFNB23 nonsyndromic deafness

Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness

RNA base editing therapy cures hearing loss induced by OTOF gene mutation.

Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness

In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model

Genome and base editing for genetic hearing loss

Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice

Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.

Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation

Virally Mediated Kcnq1 Gene Replacement Therapy in the Immature Scala Media Restores Hearing in A Mouse Model of Human Jervell and Lange-Nielsen Deafness Syndrome

Hearing of Otof-deficient Mice Restored by Trans-Splicing of N- and C-terminal Otoferlin.